All in all, we concluded that knockout of the Notch1 gene enhances the glioma therapeutic effectiveness of TMZ and further confirmed that the Notch1 gene is a key molecule in the reversal of TMZ resistance in glioma. This evidence concerns the gene NOTCH1 and central nervous system cancer.